Covaxin gets emergency use approval from DCGI for children above 12 years

Bharat Biotech informed that Covaxin is documented with excellent safety and immunogenicity data readouts in children

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/30YVs6H